Catalent

Catalent, Inc., founded in 2007 and headquartered in Somerset, New Jersey, is a leading global provider of pharmaceutical and biologic solutions. The company's core mission is to help bring more customer products to market faster, enhancing product performance and ensuring reliable supply. Catalent offers a wide range of services including delivery technologies, drug development, manufacturing, biologics, gene therapies, and consumer health products. With a strong market focus on pharmaceuticals and biotechnology, Catalent serves clients worldwide through its 52 locations.

Notable affiliated individuals include Alessandro Maselli. Catalent is publicly traded on the NYSE under the ticker CTLT and is a component of the S&P 500. Employing over 14,000 people, including approximately 2,400 scientists and technicians, Catalent generated over $3 billion in revenue in fiscal year 2020. The company has made significant impacts in accelerating drug development and enhancing drug delivery technologies, solidifying its position as a critical player in the global pharmaceutical industry.